Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Sigyn Therapeutics, Inc. (RGNP)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/26/2021 |
8-K/A
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
12/30/2020 |
8-K/A
| Financial Statements and Exhibits Interactive Data
Docs:
|
"SIGYN THERAPEUTICS, INC. Index to Financial Statements CONTENTS Page Report of Independent Registered Public Accounting Firm 2 Balance Sheet 3 Statement of Operations 4 Statement of Changes in Stockholders’ Deficit 5 Statement of Cash Flows 6 Notes to Financial Statements 7 Report of Independent Registered Public Accounting Firm To the Board of Directors and Stockholders of Sigyn Therapeutics, Inc.",
"SIGYN THERAPEUTICS, INC. Index to Financial Statements CONTENTS Unaudited Condensed Financial Statements Page Unaudited Condensed Balance Sheets 2 Unaudited Condensed Statements of Operations 3 Unaudited Statements of Changes in Stockholders’ Deficit 4 Unaudited Condensed Statement of Cash Flows 5 Notes to Unaudited Condensed Financial Statements 6 SIGYN THERAPEUTICS, INC. UNAUDITED CONDENSED BALANCE SHEETS September 30, December 31, 2020 2019 ASSETS Current assets: Cash $ 365,145 $ - Total current assets 365,145 - Intangible assets 10,199 - Total assets $ 375,344 $ - LIABILITIES AND STOCKHOLDERS’ DEFICIT Current liabilities: Accounts payable $ 1,090 $ 910 Accrued payroll taxes 22,021 - Total current liabilities 23,111 910 Long-term liabilities: Convertible notes, net of unamortized debt d...",
"SIGYN THERAPEUTICS, INC. UNAUDITED PROFORMA CONDENSED COMBINED FINANCIAL STATEMENTS" |
|
01/06/2020 |
8-K/A
| Changes in Registrant's Certifying Accountant, Other Events, Financial Statements and Exhibits |
08/07/2017 |
8-K/A
| Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits |
|
|